secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sionna Therapeutics, Inc. (SION)
CIK:        0002036042
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0002036042-25-000018
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sionna Therapeutics annual meeting elects three Class I directors, ratifies auditor
--------------------------------------------------------------------------------

- Shareholders elected Joshua Resnick, Bruce Booth, and Lucian Iancovici as Class I directors, each with over 42 million votes for.
- Ratification of Deloitte & Touche as independent auditor for FY2025 passed with 43,189,421 votes for, none against.
- Record date April 15, 2025; 44,124,394 shares outstanding; broker non-votes of 496,255 on director elections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2036042/000203604225000018/0002036042-25-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2036042/000203604225000018/sion-20250612.htm
  HTML page:      https://secwatch.observer/filing/0002036042-25-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer